Trends in prescribing for vulvovaginal candidiasis in the United States

Pharmacoepidemiology and Drug Safety
Linda F McCaig, Michael M McNeil

Abstract

To describe trends in visits to office-based physicians in the United States by females 15-64 years of age for vulvovaginal candidiasis and related antifungal prescribing. Since January 1991, intravaginal antifungal medications have been available over-the-counter in the United States to treat vulvovaginal candidiasis. Data from the 1985 through 2001 National Ambulatory Medical Care Surveys (NAMCS) were examined. NAMCS is an annual national probability sample survey that collects data on the utilization of services provided by office-based physicians. The average annual visit rates for symptoms of vaginitis and a diagnosis of vulvovaginal candidiasis decreased by 55 and 72%, respectively. The intravaginal antifungal prescribing rate for vulvovaginal candidiasis declined by 41%. No trend was found for total antifungal prescribing; however, during the late 1990s, fluconazole was prescribed at approximately one-third of visits with a diagnosis of vulvovaginal candidiasis. These data suggest an increased trend in self-diagnosis and use of over-the-counter intravaginal antifungal medications. The shift from prescribing intravaginal antifungal preparations to fluconazole raises concern about the possible development of azole drug res...Continue Reading

References

Oct 1, 1991·American Journal of Obstetrics and Gynecology·H L Kent
Sep 1, 1990·Archives of Internal Medicine·V M SchaafK Borchardt
Sep 1, 1995·American Journal of Obstetrics and Gynecology·P NyirjesyH R Buckley
Aug 1, 1995·American Journal of Public Health·A M GeigerB W Gillespie
Jun 1, 1995·Obstetrics and Gynecology·A SpinilloG Piazzi
Apr 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J D Sobel, J A Vazquez
Apr 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J D Sobel, W Chaim
Sep 24, 1999·Pediatric Clinics of North America·P Nyirjesy
Apr 27, 2000·Sexually Transmitted Diseases·B FoxmanJ D Sobel
May 29, 2000·The Journal of the American Board of Family Practice·M S LipskyL K Sharp
Jul 31, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B MathemaD S Perlin
Aug 2, 2001·The Journal of Antimicrobial Chemotherapy·S NatschB J Kullberg
Aug 2, 2002·Expert Opinion on Pharmacotherapy·Jack D Sobel
Sep 19, 2002·American Journal of Obstetrics and Gynecology·Tiene G m BautersHans J Nelis
Oct 18, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shivani SinghJose A Vazquez
Jan 7, 2003·Infectious Disease Clinics of North America·Jose A Vazquez, Jack D Sobel

❮ Previous
Next ❯

Citations

Feb 11, 2005·BMC Clinical Pharmacology·Katja de WithWinfried V Kern
Sep 12, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kaitlin BenedictKarlyn D Beer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.